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Autism spectrum disorders are a group of highly heritable neurodevelopmental disorders with
a complex genetic etiology. The International Molecular Genetic Study of Autism Consortium
previously identified linkage loci on chromosomes 7 and 2, termed AUTS1 and AUTS5,
respectively. In this study, we performed a high-density association analysis in AUTS1 and
AUTS5, testing more than 3000 single nucleotide polymorphisms (SNPs) in all known genes in
each region, as well as SNPs in non-genic highly conserved sequences. SNP genotype data
were also used to investigate copy number variation within these regions. The study sample
consisted of 127 and 126 families, showing linkage to the AUTS1 and AUTS5 regions,
respectively, and 188 gender-matched controls. Further investigation of the strongest
association results was conducted in an independent European family sample containing
390 affected individuals. Association and copy number variant analysis highlighted several
genes that warrant further investigation, including IMMP2L and DOCK4 on chromosome 7.
Evidence for the involvement of DOCK4 in autism susceptibility was supported by
independent replication of association at rs2217262 and the finding of a deletion segregating
in a sib-pair family.
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Introduction
Autism (OMIM: %209850) is a complex neurodeve-
lopmental disorder characterized by impairments in
reciprocal social interaction, difficulties in verbal and
nonverbal communication, stereotyped behaviors and
interests, and an onset in the first 3 years of life.
Autism belongs to the group of pervasive develop-
mental disorders (PDD), also known as autism
spectrum disorders (ASDs), which also include
Asperger syndrome and pervasive developmental
disorder—not otherwise specified (PDD-NOS). The
estimated population prevalence of core autism is
around 15–20 in 10000, with a male/female sex ratio
of approximately 4:1. When all ASD subtypes are
combined the prevalence is several times higher,
reaching 116 in 10000.
1–3
Several lines of evidence indicate that genetic
factors are important in susceptibility to idiopathic
Received 20 October 2008; revised 19 February 2009; accepted 2
April 2009; published online 28 April 2009
Correspondence: Professor AP Monaco, Wellcome Trust Centre
for Human Genetics, University of Oxford, Roosevelt Drive,
Oxford OX3 7BN, UK.
E-mail: anthony.monaco@well.ox.ac.uk or Professor AJ Bailey,
University Department of Psychiatry, Warneford Hospital, Head-
ington, Oxford OX3 7JX, UK.
E-mail: Anthony.Bailey@psych.ox.ac.uk
11These authors contributed equally to this work.
12IMGSAC: see list of authors in Supplementary Information.
Molecular Psychiatry (2010) 15, 954–968
& 2010 Macmillan Publishers Limited All rights reserved 1359-4184/10
www.nature.com/mpautism. Twin studies show a concordance of 60–92%
for monozygotic (MZ) twins and 0–10% for dizygotic
(DZ) twins, depending on phenotypic definitions, and
the sibling recurrence risk is 25–60 times higher than
the population prevalence.
4 Furthermore, relatives of
affected probands show a higher incidence of milder
cognitive or behavioral features, consistent with the
hypothesis of a ‘spectrum’ of severity.
5
Autism spectrum disorders exhibit wide clinical
variability and a high degree of genetic heterogeneity.
A variety of chromosomal abnormalities are found in
a small proportion of affected individuals (6–7%),
most frequently in syndromic cases with dysmorphic
features and cognitive impairment.
6 The autism
phenotype is also associated with known genetic
conditions such as the Fragile X syndrome and
tuberous sclerosis. Recently, rare ASD-causing muta-
tions were reported in a number of genes, including
NLGN3, NLGN4,
7 NRXN1,
8 SHANK3
9 and NHE9.
10
In recent years, the development of DNA micro-
array technologies has revealed that submicroscopic
deletions and duplications of DNA, known as copy
number variants (CNVs), may be significant in autism
susceptibility.
11–14 Recent surveys identified a higher
rate of de novo CNVs in autism pedigrees compared to
controls, with the increased rate becoming more
exaggerated in singleton than in multiplex fa-
milies.
10,12,13 Nevertheless, it remains difficult to
interpret the significance of the numerous CNVs
identified in ASDs, to distinguish those that influence
susceptibility from normal polymorphic variation and
to understand how they might interact with other
genetic and non-genetic factors.
Although individually rare, highly penetrant ab-
normalities, such as microdeletions/microduplica-
tions or point mutations, may have a significant
function in ASDs. It is also likely that genetic
susceptibility may also result from the combined
action of several common genetic variants. Common
variation in several candidate genes has been im-
plicated in autism (MET, CNTNAP2, SLC6A4, RELN,
GABRB3),
15 but in most cases consistent replication
has not been achieved.
Because the strong genetic component in ASDs was
clearly demonstrated over a decade ago, a large
number of molecular genetic studies have searched
for susceptibility genes, following the general ap-
proach of a genome-wide linkage scan using affected
sibling/relative pair families. The International Mole-
cular Genetic Study of Autism Consortium (IMGSAC)
identified the first autism linkage locus on chromo-
some 7q21–q32 (designated autism susceptibility
locus 1, AUTS1) with a multipoint maximum LOD
score (MLS) of 2.53 in 87 families.
16 This result was
confirmed in follow-up studies conducted by the
IMGSAC using additional families and markers.
17,18
Another linkage susceptibility locus (AUTS5) was
identified by IMGSAC on chromosome 2q24–q33
with an MLS of 3.74 in 152 affected sibling pairs.
17
Replication of linkage signals in independent
studies has proven difficult for ASDs. To date, 13
whole-genome linkage scan for ASDs have been
published,
15 and no single locus has been consis-
tently confirmed in all studies. This finding is likely
to result from the small effect size attributable to
individual genes, as well as from the clinical and
genetic complexity of ASDs; differences in ascertain-
ment and inclusion criteria may have been additional
factors. However, AUTS1 is one of the few identified
loci that has been supported by overlapping positive
results in multiple multiplex collections,
19,20 and in
meta-analyses.
21,22 Similarly, the chromosome 2q
locus is supported by overlapping linkage findings
in another two independent genome scans,
23,24 and by
homozygosity mapping in consanguineous families.
10
The largest genome scan published to date, carried
out by the Autism Genome Project (AGP) using
Affymetrix 10K single nucleotide polymorphism
(SNP) arrays and 1181 multiplex families, also
provided some support for both the chromosome 2q
and 7q loci within the families of inferred European
ancestry.
8
Despite the support for linkage on chromosomes 2q
and 7q, the candidate genomic intervals remain
broad, each spanning approximately 40Mb and
containing approximately 200 known genes. Systema-
tic screening and association studies of several
positional candidate genes on chromosomes 2q and
7q have been conducted by the IMGSAC,
25–29 but
these studies have not led to the identification of
confirmed autism susceptibility variants. Owing to
the recent technological advances in high-density
SNP genotyping and bioinformatic resources, we
focused our efforts on performing a gene-based high-
density SNP association study of the autism suscept-
ibility loci on chromosomes 2q and 7q implicated by
IMGSAC linkage studies. SNP genotype data were
also used to investigate copy number variation within
these regions. The genetic architecture of ASDs is
likely to be extremely complex, with disease risk
determined by both common variants of modest
effect, as well as rare variants with a range of effect
sizes. The strategy of focusing on linkage regions for
fine-mapping studies by high-density association
screens will prioritize genes containing penetrant
rare variants, which would not be well identified
through association analysis. However, we might
expect that genes containing such variants also
contain more common variants of lesser effect and
thus are still natural candidates to follow-up through
association studies.
Genotyping was conducted in two stages, based on
HapMap Phase I and Phase II data, respectively. In
total, 3002 SNPs were genotyped in each region,
directly testing 173 genes on chromosome 2 and 270
genes on chromosome 7. The study sample consisted
of 126 and 127 affected individuals and their parents,
selected from 293 IMGSAC multiplex families based
on identity-by-descent (IBD) sharing on chromosomes
2q and 7q, respectively, as well as 188 gender-
matched controls. This study design, where the same
probands are used for family-based and case–control
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Molecular Psychiatryanalysis, should be more robust against the respective
weaknesses of the case–control and TDT approaches
(such as population structure and segregation distor-
tion, respectively), and extract the maximum informa-
tion from our sample.
30 Moreover, by selecting
families showing excess allele sharing in the region
of interest, we are likely to increase the frequency
of the disease-associated alleles in the case
sample, thereby increasing the power of association
studies.
31 Power calculations were performed over a
range of risk allele frequencies and odds ratios (OR),
confirming that the strategy of selecting families
for increased IBD sharing outperformed a strategy
in which families are selected at random, given
fixed genotyping resources (see Supplementary
Information).
Our study thus represents a deep exploration of
SNP and copy number variation within genic regions
of the two autism linkage loci on chromosomes 2q
and 7q and pinpoints several genes that need further
investigation.
Materials and methods
Study populations
The chromosome 2 primary sample included 126
independent autism families, for 371 individuals (119
parent–parent–child trios and 7 single parent–child
pairs). The chromosome 7 primary sample included
127 independent autism families (117 parent–parent–
child trios and 10 single parent–child pairs). All
families were Caucasian (Table 1). The assessment
methods and diagnostic criteria used by the IMGSAC
have been described in detail previously.
17 Diagnosis
was based on the Autism Diagnostic Interview—
Revised (ADI-R) and the Autism Diagnostic Observa-
tion Schedule (ADOS) and clinical evaluation. Kar-
yotypes were obtained on all affected individuals
when possible, and gross karyotypic abnormalities
were excluded in at least one affected individual per
family in 93% of families and in both affected
individuals in 83% of families.
Trios for the primary sample were selected from the
293 multiplex families in the IMGSAC multiplex
collection (using one affected sib per family) based on
IBD sharing on chromosomes 2q and 7q, respectively.
Calculation of IBD states was based on microsatellite
marker data available from our genome scan
18 and
fine-mapping studies (unpublished data). Ranked
Z-scores were calculated for each family using
Merlin
32 at the linkage peak position (D2S2302-
D2S2310 and D7S2430-D7S684 for chromosomes 2
and 7, respectively).
Two main sample collections were used for replica-
tion (Table 1): (1) ‘IMGSAC replication’ (IMGSAC-R)
sample: 260 parent-affected child trios or pairs and 34
single cases and (2) ‘Northern Dutch’ sample (ND): 96
singleton families from the north of the Netherlands,
including 82 parent–parent–child trios and 14 par-
ent–child pairs. Both replication sample collections
fulfilled diagnostic criteria for Case ‘Type 1’ or ‘Type
T
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Molecular Psychiatry2’ as defined by IMGSAC
17 (meet ADI-R criteria or one
point below threshold on one behavioral domain,
meet ADOS/ADOS-G criteria for autism or PDD,
performance IQ>35). An extended Northern Dutch
sample (ND-all; Table 1) was available, including 108
cases that did not meet stringent criteria for one of the
following reasons: (1) met ADI-R criteria but failed to
meet ADOS criteria or did not undergo ADOS
evaluation, (2) met ADI-R and ADOS criteria but
had an IQ score <35, (3) did not meet full criteria for
ASD on the ADI-R.
The most significant SNPs from the chromosome 2
locus were also tested in a collection of 358 multiplex
families (‘Mount Sinai’ sample), which have been
previously described.
23,33 Similarly, three SNPs from
two of the most strongly associated genes in the case–
control and family-based analysis on chromosome 7
were genotyped in 62 Caucasian families selected for
IBD sharing from a sample of 222 families showing
linkage to the same region of chromosome 7
19
(‘University of Washington’ sample).
Controls used in the primary experiment included
188 DNA samples from UK random blood donors
from the ECACC HRC panels,
34 sex-matched with the
autism case sample. The additional set of 180 controls
genotyped in the replication phase included 92 DNAs
from ECACC HRC panels, 41 random donors from the
UK and 47 random donors from Italy.
The study was reviewed by the relevant local ethics
committees.
Genotyping
Single nucleotide polymorphisms for the primary
analysis were genotyped using the GoldenGate assay
(Illumina, San Diego, CA, USA) on an Illumina
BeadStation according to the manufacturer’s instruc-
tions. BeadArrays were scanned using the BeadArray
Reader at 532 and 647nm. BeadStudio genotyping
module (version 3.2.23) was used to generate genotypes.
Genotyping was conducted in two parallel stages
for both chromosomal loci. A total of 3072 SNPs were
genotyped in each stage using two custom 1536-plex
Illumina arrays, one for each chromosome. The
regions of interest ranged from 94.246 to 136.661Mb
on chromosome 7 and from 152.305 to 191.605Mb on
chromosome 2 (NCBI Build 36). These intervals were
defined using the approximate 1-LOD drop of the
linkage peaks on the two chromosomes, based on
IMGSAC microsatellite marker data.
18
In the first stage of this study, we evaluated the
patterns of linkage disequilibrium (LD) and the
distribution of haplotype blocks in the CEU genotype
data from the HapMap project release 13 (HapMap
Phase I data). Genic regions were defined by NCBI
Build 34, by merging all RefSeq and UCSC Known
Genes, including all exonic, intronic and 30 UTR
sequences, as well as 5kb upstream of the 50 end. A
total of 1496 tag SNPs on both chromosome 2q and 7q
were identified using HaploView
35 and the Gabriel
algorithm for block definition from LD blocks over-
lapping all genic regions.
In the second stage of genotyping, we took
advantage of the higher-density HapMap Phase II
data to better represent genetic variation in regions of
lower LD not previously captured by the HapMap
Phase I data. We also used the latest genome
annotation (NCBI Build 36) to investigate novel genes
and ensure comprehensive coverage of all intragenic
and putative regulatory regions on both chromo-
somes. We identified ‘non-genic’ evolutionary con-
served regions from PhastCons elements.
36 We
downloaded SNP genotype data from the CEU
population from HapMap release 22, and selected
all SNPs in all genic regions and in the top 5% of non-
genic PhastCons elements. We also selected all
nonsynonymous SNPs with minor allele frequency
(MAF) X0.05. We then used the Tagger program from
HaploView
35 (version 4) to select a second set of 1516
tag SNPs for each chromosomal region. Parameters
used for Tagger were r
2X0.75 (chromosome 2) and
r
2X0.63 (chromosome 7), minimum MAF of 5%,
aggressive tagging and force including SNPs already
genotyped in stage 1. We estimated that our two sets
of SNPs were able to tag 96 and 85% of intragenic
HapMap SNP variation (MAF>0.05) with r
2>0.8 on
chromosomes 2 and 7, respectively.
Genotypes for 212 SNPs (99 on chromosome 2 and
113 on chromosome 7), previously generated by the
AGP using the Affymetrix 10K version 2 SNP array,
8
were available on the IMGSAC family sample and
were also included in the family-based association
analysis.
A total of 50 genome-wide unlinked SNPs were
genotyped for detection of population stratification,
37
and 10 chromosome X SNP were also included to
estimate levels of mistyping. In addition, for regions
of high LD, where tagging SNPs captured the most
genetic variation, extra SNPs were chosen in case of
genotyping failure.
Replication SNP genotyping
Single nucleotide polymorphisms for replication
were genotyped using a combination of the Mass
Extend iPLEX Gold (Sequenom, San Diego, CA, USA)
and TaqMan platforms. A 100% genotyping concor-
dance was observed for two replicate DNA samples
genotyped in each experiment. Twenty-five genome-
wide SNPs were also genotyped in the IMGSAC-R
sample to test for population stratification.
Statistical analysis
Association analysis. We evaluated evidence of
association using both ‘frequentist’ and Bayesian
statistical approaches.
Primary association analysis of the 5880 SNPs
(including the 212 SNPs available from the AGP
linkage study
8) successfully genotyped in the
IMGSAC data set at the two loci was carried out
using the PLINK package.
38 To extend the amount
of information captured by single-marker tests, an
additional set of two-marker haplotype tags was
SNP association and CNV analysis of AUTS1 and AUTS5
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program
39 implemented in HaploView.
35 In total, 3526
tests (2959 single-marker tests and 567 haplotype
tags) were performed for the chromosome 2 study, and
3380 tests (2921 single-marker tests and 459 haplo-
type tags) for the chromosome 7 study.
Standard TDT from PLINK was used for family-
based analysis, and the Cochran–Armitage trend test
(1 degree of freedom) for the case–control analysis.
Haplotype-based tests were calculated using PLINK.
Bayesian logistic regression analysis was performed
using the GENEBPM algorithm,
40,41 again using both a
case–control and family-based approach (see Supple-
mentary Methods). The logistic regression model
allowed for additive and dominance effects of un-
observed causal variants, a main effect of gender as
well as for parent-of-origin effects in the family-based
analysis. GENEBPM analyses were performed using a
sliding window of five SNPs across each chromosomal
region. For comparison with frequentist single-SNP
analyses, the GENEBPM algorithm was also applied to
each SNP in turn (that is, single-SNP ‘haplotypes’).
Replication analysis
Association analysis of the IMGSAC-R and ND repli-
cation data sets was carried out using the UNPHASED
package,
42 given the presence of a higher proportion
of families with missing parents (24%) (Table 1).
UNPHASED implements maximum-likelihood-based
association analysis for nuclear families and unrela-
ted subjects allowing for missing genotypes and
uncertain haplotype phase. In the presence of missing
data it has only minor loss of robustness to population
stratification and is more powerful than standard
TDT.
42
Analysis of the combined primary and replication
cohorts was also carried out using UNPHASED, again
using both a case–control approach and a family-
based approach. Only the IMGSAC and IMGSAC-R
data sets were combined for the population-based
meta-analysis, because appropriate controls were not
available for the ND population.
Copy number variation
We used transmission patterns of SNP genotypes
within parent–offspring families to detect Mendelian
errors consistent with the presence of a deletion. In
addition, the clustering of all SNP genotypes was
visually examined to identify abnormal clustering
patterns or outlying samples that might point to CNVs
associated with the autism phenotype. Sequencing
was carried out to confirm the presence of microdele-
tions, CNVs or secondary SNPs.
After exclusion of whole-genome amplified sam-
ples, data from both GoldenGate arrays were com-
bined for each region, no-calls were deleted, and run
on QuantiSNP version 1.0.
43 CNV validation and
screening was carried out by multiplex PCR and
quantitative multiplex PCR of short fluorescent frag-
ments (QMPSF).
44 Positive results were confirmed in
a second independent QMPSF assay.
The distal breakpoint of the deletion detected in
family 15-0084 was better defined by quantitative
PCR (qPCR) of DOCK4 exons 52, 37, 31, 14 and 7, with
GAPDH as a reference.
Additional information is available as Supplemen-
tary Methods.
Results
Genotyping
A total of 6004 SNPs—3002 in each chromosome
region—were genotyped using the Illumina Gold-
enGate technology. After quality control procedures,
we excluded 336 markers for one or more of the
following reasons: MAF<0.05, more than 1 Mende-
lian error, genotyping rate <90%, poor clustering and
deviations from Hardy–Weinberg equilibrium
(P<0.001) in the control population.
For the 5668 (94%) SNPs that passed quality
control, the genotyping efficiency exceeded 99.7%,
with an estimated error rate from duplicate SNPs and
from heterozygote calls of X chromosome SNPs in
males in the order of 2–5 10
 4. In summary, 2860
SNPs from the chromosome 2q23.3–q32.3 region were
successfully genotyped in 559 DNA samples includ-
ing 126 affected individuals, 245 parents and 188
gender-matched controls from the ECACC collection;
2808 SNPs from the chromosome 7q21.3–q33 region
were successfully genotyped in 559 DNA samples
including 127 affected individuals, 244 parents and
188 ECACC gender-matched controls. In addition, our
family-based analysis included genotypes from 212
SNPs (99 on chromosome 2 and 113 on chromosome
7), which were generated by the AGP using the
Affymetrix 10K version 2 SNP array.
8
There was no significant difference in the pattern of
LD between our sample and the HapMap CEU sample,
indicating that the LD structure in the HapMap CEU
data can be readily applied to our autism sample.
SNPs were selected to capture efficiently the large
majority of the currently known variation in all
intragenic regions and highly conserved non-genic
elements (see Supplementary Methods).
Population stratification
The presence of stratification in a population-based
association study that is not suitably accounted for in
case–control analysis can lead to an increase in the
false-positive error rate. Furthermore, haplotype
analyses in family-based association studies are not
robust to population stratification if random mating is
assumed among parents in the haplotype estimation
step.
We tested for population structure in our primary
IMGSAC sample using Structure
45,46 software, and
testing 50 unlinked genome-wide SNPs. Comparing
the fit of the admixture model for K=1, 2 and 3 strata,
we found strongest support for a model of no
stratification (K=1) in both of the following groups
of individuals: (1) probands, controls and HapMap
CEU founders; and (2) parents and HapMap CEU
SNP association and CNV analysis of AUTS1 and AUTS5
E Maestrini et al
958
Molecular Psychiatryfounders. Similarly, no evidence of stratification was
detected in the combined IMGSAC primary and
IMGSAC-R sample, using 25 unlinked genome-wide
SNP markers. These results reassure us that no strong
population stratification is present in our IMGSAC
primary and IMGSAC-R sample.
Association analysis
The results of the case–control (Cochran–Armitage
trend test) and family-based analysis (TDT) are shown
in Figure 1 and summarized in Table 2.
Chromosome 2 association results
Three SNPs in the NOSTRIN gene provided the
strongest association in the case–control analysis
(rs7583629, P=3.2 10
 5; rs829957, P=9.0 10
 5;
rs482435, P=1.4 10
 4), followed by rs1020626
(P=3.8 10
 4) in the FAM130A2 gene.
For the TDT analysis the strongest results came
from SNPs in the ZNF533 gene (rs11885327,
P=8.0 10
 4; rs1964081, P=1.4 10
 3), and an SNP
in the UPP2 gene (rs6709528, P=8.0 10
 4).
Single-marker logistic regression analysis provided
a similar ranking of results. In the case–control analy-
sis the most strongly associated SNP rs7583629 in
NOSTRIN provided a log10 Bayes factor (logBF) of 2.9,
whereas in the family-based analysis the top signal
was for rs1139 in the ZNF533 gene (logBF=1.7).
GENEBPM multimarker analysis using 5-SNP sliding
windows (Supplementary Figure S1) showed in-
creased evidence in favor of association for the
NOSTRIN locus (logBF=3.2) in the case–control
analysis, but did not identify additional interesting
signals. Family-based multimarker analysis revealed
an additional association signal with a haplotype
spanning 75kb in the METTL8 gene (logBF=2.3).
Chromosome 7 association results
The strongest signal for the case–control (trend test)
analysis was from IMMP2L (rs12537269, P=1.2 10
 4;
rs1528039, 6.3 10
 4) and just upstream of SMO
(rs6962740, P=3.4 10
 4). The TDT test implicated
Plexin A4 (PLXNA4; rs4731863, P=1.0 10
 4) and
cut-like homeobox 1 isoform b (CUX1; rs875659,
P=2.0 10
 4).
Single-marker logistic regression analysis provided
a similar ranking of results in the case–control
analysis with rs12537269 (logBF=2.9) in IMMP2L
showing the most significance. In the family-based
analysis, the most significant result was seen for
rs4730037 in LHFPL3 (logBF=2.1), closely followed
by rs4731863 in PLXNA4 (logBF=2.0). Moreover,
GENEBPM revealed a parent-of-origin effect in the
IMMP2L locus, with increased risk for causal variants
inherited from the father compared to those inherited
from the mother. For this reason we investigated SNPs
in IMMP2L by parent-specific TDT, which revealed a
P-value of 0.01 for rs2030781, with a transmitted/
untransmitted allele ratio of 31:14 for paternal
transmissions (Table 2).
GENEBPM multimarker analysis using 5-SNP slid-
ing windows showed increased evidence of associa-
Figure 1 Graphical representation of chromosome 2 and 7 association results.  Log10 P-values are plotted against the
chromosome position. (a) P-values obtained for single markers (Cochran–Armitage trend test) and 2-SNP haplotype case–
control association (PLINK). (b) P-values for single-marker TDT and 2-SNP haplotype TDT.
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Molecular Psychiatrytion for the IMMP2L locus in the case–control analysis
(logBF=2.9) and for PLXNA4 (logBF=2.9) in the
family-based analysis, but did not identify additional
interesting signals (Supplementary Figure S1).
Analysis of the LD landscape across the AUTS1
region, using both HapMap (CEU) and data from the
127 probands used in our primary sample, indicated
that the six associated SNPs in IMMP2L (Table 2) are
all within a single block of LD, and thus likely to be
indexing the same effect. In contrast, the modest
association seen in the first intron of the neighboring
DOCK4 gene was in a separate block of LD.
Replication
We attempted replication of 56 SNPs (28 on each
chromosome) that attained the most significant associa-
tion results in primary case–control and TDT analyses
(Table 3; Supplementary Table S1). The replication
population consisted of the IMGSAC-R and the ND
collections, including 390 affected individuals (see
Table 1; Materials and methods for a description of
samples). Family-based analysis of the replication
sample showed significant overtransmission of the
common allele of SNP rs2217262 in the DOCK4 gene
(P=9.2 10
 4, OR=2.28, confidence interval 1.37–3.77)
(Table 3; Supplementary Table S1). This result remains
significant after Bonferroni correction for multiple
testing (28 SNPs tested on chromosome 7, P=0.026).
The trend toward association of rs2217262 (P=0.029)
was also seen in the extended ND sample, which
included additional subjects fulfilling broader diag-
nostic criteria (ND-all, 204 affected subjects; Table 1).
The remaining SNPs did not show significant
replication after correction for multiple testing, and
no parent-of-origin effects were seen for rs2030781.
Finally, the 56 SNPs selected for replication
were investigated in the combined primary and
replication data sets; only 7 SNPs attained uncor-
rected significance of P<0.001 (Table 4). The DOCK4
SNP rs2217262 reached a nominal significance of
P=5.23 10
 5 in the family-based analysis of all
cohorts (IMGSAC primary, IMGSAC-R and ND). In the
case–control analysis of the combined IMGSAC
collections (421 cases and 368 controls), rs12537269
in IMMP2L achieved the most significant result
(P=7.3 10
 5). Additional loci retaining association
evidence in case–control meta-analysis were ZNF533
on chromosome 2, and TSPAN12, FEZF1 and
SLC13A1 on chromosome 7.
Several SNPs in the most interesting genes from the
primary analysis were also tested in two additional
family collections, which had previously shown
evidence of linkage to the chromosome 2q and 7q
loci
19,23,33 (Supplementary Table S1). Five SNPs in
NOSTRIN, ZNF533 and OSBPL6 were tested in a
sample of 358 multiplex families (‘Mount Sinai’
cohort),
23,33 but no significant results were obtained.
Of the 28, 3 AUTS1 replication SNPs in IMMP2L and
CUX1 were genotyped in 62 Caucasian families
selected for IBD sharing from 222 families showing
linkage to the same region of chromosome 7
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Molecular Psychiatry(‘University of Washington’ sample),
19 again with no
evidence for association.
Copy number variation
A Mendelian error in one family for SNP rs7585982
pinpointed a potentially interesting deletion in the
UPP2 gene on chromosome 2. The deletion bound-
aries were defined by sequence analysis of additional
SNPs flanking rs7585982. Using long-range PCR
followed by sequencing, we refined the deletion
to 5897bp of the UPP2 gene (158681612–
158687508bp; UCSC Build 36), removing two coding
exons (exons 6 and 7) and predicted to cause a
frameshift leading to a premature termination codon
(Supplementary Figure S2A). This deletion was not
present in the Database of Genomic Variants (DGV,
http://projects.tcag.ca/variation/), suggesting it could
be an autism-specific CNV. We screened the same
sample used for the SNP association experiment (126
cases and 188 controls) for the presence of this
deletion using multiplex PCR (Supplementary
Figure S2B). The frequency of the deletion was not
significantly different between cases and controls
(1.6 and 3.2%, respectively, P=0.2). To investigate if
the deletion segregates with the ASD phenotype,
we also screened 265 sib-pair families from the
IMGSAC collection, including relatives of the 126
cases. Of these, we found 30 families with a parent
carrying the deleted allele, and in only 13
families was it transmitted to affected children
(in 5 families to both affected siblings and in 8
families to a single affected individual). These
results suggest that the UPP2 deletion is not involved
in autism susceptibility. The coding sequence of
UPP2 was also sequenced in 47 unrelated subjects,
including 12 probands carrying the deletion of exons
6 and 7; no novel coding variants were identified,
except one silent change in exon 4 in only one
individual.
By combining data from both SNP arrays for each
candidate region, a sufficient SNP density was
achieved to carry out copy number analysis on these
samples using QuantiSNP.
43 We detected 17 CNVs in
seven regions of chromosome 7 and 6 CNVs in five
regions of chromosome 2 (Supplementary Table S2).
For the chromosome 7 analysis, an B800kb duplica-
tion was detected in family 13-3023 that was
transmitted from father to proband (Supplementary
Figure S3). This duplication includes two genes:
IMMP2L and DOCK4. Another duplication overlap-
ping EMID2 and RABL5 was detected in three families
where it was transmitted from mother to proband,
whereas a smaller duplication containing only EMID2
was detected in a father, but not transmitted, and in
one control. A third CNV in EXOC4 was detected as a
nontransmitted loss in a father and as a gain (four
copies) in a control.
On chromosome 2, five duplications and one
deletion were detected in parents and a single
control, but never transmitted to an affected child
(Supplementary Table S2).
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Molecular PsychiatryMost of the identified CNVs are well represented in
the DGV, suggesting that they do not have a major
function in autism susceptibility. However, the
duplication involving IMMP2L and DOCK4 warranted
further analysis, as it involved two adjacent genes
showing possible SNP association with autism.
Therefore we developed a QMPSF assay able to
simultaneously test CNVs in exons 2, 3 and 6 of
IMMP2L, exon 4 of LRRN3 and the last exon of DOCK4
(number 52). We validated the duplication in family
13-3023, identified by QuantiSNP, and verified that it
is transmitted from the father to the affected son, but
it was not transmitted to the other affected sib or to an
unaffected sib. Screening of 475 UK controls and 285
IMGSAC multiplex families with 487 affected indivi-
duals was then carried out using the QMPSF assay,
to check if CNVs in these genic regions segregated
with the autism phenotype in families and/or have a
higher frequency in cases than controls. We identified
six additional deletions of different length, of which
some were transmitted. One deletion disrupted exons
2 and 3 of IMMP2L and the last exon of DOCK4, and
was transmitted from the mother to both affected
sons, as well as to a daughter, who did not have an
ASD. Both the carrier mother and daughter were
reported to have dyslexia. qPCR indicated that the
deletion distal breakpoint is located between exons
31 and 14 of DOCK4 (Supplementary Figure S4). Two
smaller deletions were transmitted from the parent to
only one of their affected children, one was found
only in the father but not transmitted and the other
two were found in controls. The relative length
and position of the CNVs identified are depicted in
Figure 2.
Discussion
Several linkage studies have suggested that chromo-
somes 2q and 7q may harbor one or more genes
contributing to the risk for developing an ASD. Here,
we have presented a comprehensive high-density
SNP genotyping, association and CNV study covering
the 2q23.3–q32.3 and 7q21.3–q33 chromosome re-
gions. We have tested more than 3000 SNPs in each
region, covering all known genes, as well as in highly
conserved non-genic sequences.
The complementary case–control and family-based
approach taken in our study allowed us to extract the
maximum information from our sample, taking into
consideration the advantages and disadvantages of
the two different approaches. Case–control studies
are more powerful compared to family-based ap-
proaches, but are sensitive to the presence of popula-
tion stratification. Structure analysis using 50
genome-wide SNPs did not reveal strong population
stratification, although we cannot exclude that un-
detected low levels may be present. Family-based
approaches are more robust to confounding by
population stratification and in addition they enable
testing for parent-of-origin effects.
Table 4 Combined analysis of primary and replication samples
All samples combined
a
Family-based analysis
IMGSAC samples combined
b
Case–control analysis
Chr SNP Gene location Risk allele P-value
(Ca-Co Freq)
OR (CI) P-value
(Ca-Co Freq)
OR (CI)
2 rs7590028 ZNF533 intronic T 0.3227 6.56E-04 1.41
(0.52, 0.50) (0.54, 0.45) (1.16–1.72)
7 rs2030781 IMMP2L intronic C 0.08613 4.63E-04 1.53
(0.25, 0.22) (0.27, 0.19) (1.20–1.95)
7 rs12537269 IMMP2L intronic A 0.01047 7.26E-05 1.62
(0.27, 0.22) (0.27, 0.19) (1.27–2.06)
7 rs2217262 DOCK4 intronic A 5.23E-05 2.37 1.75E-03 2.08
(0.96, 0.92) (1.53–3.68) (0.96, 0.92) (1.31–3.32)
7 rs41620 30 of TSPAN12 A 0.08796 8.14E-04 1.48
(0.77, 0.74) (0.78, 0.71) (1.18–1.86)
7 rs538558 30 of FEZF1 A 0.4688 5.77E-04 1.45
(0.36, 0.34) (0.37, 0.28) (1.17–1.80)
7 rs11978485 30 of SLC13A1 G 0.04972 2.89E-04 1.59
(0.82, 0.79) (0.84, 0.76) (1.24–2.04)
Abbreviations: Ca-Co freq, risk allele frequency in affected offspring and in untransmitted parental alleles (family-based) or
in control (case–control); IMGSAC, International Molecular Genetic Study of Autism Consortium; OR (CI), odds ratio and
95% confidence interval; SNP, single nucleotide polymorphism.
Results generated by UNPHASED. Only SNPs with nominal P<0.001 are shown. P-values<0.001 are in bold.
aIMGSAC primary sample, IMGSAC-R, ND (515–516 affected individuals).
bIMGSAC primary sample, IMGSAC-R (420–421 cases, 368 controls).
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Molecular PsychiatryAlthough the strongest signals identified by the two
approaches did not coincide, comparison of the
results led us to pinpoint the most interesting loci
supported by both methods, albeit with different
strength. In addition, consistency of the results
obtained by frequentist and Bayesian approaches
suggested that our strongest signals are independent
of the analysis method.
Primary association analysis of the chromosome 2
region identified the most interesting results in
NOSTRIN, UPP2 and ZNF533. NOSTRIN encodes
the nitric oxide synthase trafficker. Interestingly, the
nitric oxide signaling pathway has been recently
shown to be overrepresented in genes disrupted by
CNVs in schizophrenia.
47 However, the NOSTRIN
association was stronger in the case–control analysis
with only minor support from the TDT, and it was
not confirmed in the replication sample or in the
combined meta-analysis, suggesting that it might
represent a false-positive result.
Similarly, the ZNF533 association was not repli-
cated, however rs7590028 remained one of the
strongest signals in case–control combined analysis
of IMGSAC samples. ZNF533 encodes a protein
containing four matrin-type zinc fingers and is highly
conserved in evolution. Given its putative nuclear
location, it is thought to act as a repressor of
transcription, although no specific targets are cur-
rently known. ZNF533 is widely expressed in adult
tissues, including brain. Expression of all isoforms in
fetal brain was confirmed by reverse transcriptase–
PCR (data not shown). Deletions including ZNF533
have been described in several patients with a
neurological phenotype including mental retarda-
tion,
48,49 and other zinc-finger genes have also
been implicated in mental retardation cases.
50–52 The
zinc-finger gene ZNF804A was recently identified as
the strongest result in a genome-wide association
study of schizophrenia and bipolar disorder,
53 sug-
gesting that they may act as transcription regulators in
a wide range of human cognitive processes.
On chromosome 7, the most significant association
result from the primary cohort was in the IMMP2L
gene. Although SNPs in this gene failed to replicate in
independent samples, the IMMP2L intronic SNP
rs12537269 achieved the strongest result in the
case–control meta-analysis of the IMGSAC sample
(P=7.3 10
 5). This gene encodes an inner mitochon-
drial membrane protease-like protein and is a plau-
sible candidate for autism, because it was previously
reported to be disrupted in an individual with
Tourette syndrome, a complex neuropsychiatric dis-
order showing phenotypic overlap with ASDs.
54
Moreover, IMMP2L contains a neuronal leucine-rich
repeat gene (LRRN3) nested within its large third
intron. The expression profile of LRRN3 also makes it
an interesting candidate gene for autism, as it is most
highly expressed in fetal brain. Studies in Drosophila
Figure 2 Summary of IMMP2L and DOCK4 copy number variants (CNVs). Fragments tested by QMSPF are shown as red
bars at the top. CNVs from the Database of Genomic Variants (DGV) are shown as orange bars. Deletions and duplications
identified in affected individuals and in parents or controls are depicted at the bottom. Dashed and continuous lines indicate
the maximum and minimum length of the CNVs, respectively. The distal breakpoint of the deletion in pedigree 15-0084 was
defined by qPCR. The distal breakpoint of the duplication in pedigree 13-3023 was not defined precisely.
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Molecular Psychiatrydemonstrate that many members of the LRR family
provide an essential role in target recognition, axonal
pathfinding and cell differentiation during neural
development,
55 and murine studies suggest these LRR
proteins could have similar functions in mammalian
neural development.
56
The only SNP that achieved significant replication,
after Bonferroni correction for multiple testing, is
rs2217262 in the neighboring gene DOCK4, also a
good autism candidate. This gene encodes a protein
that activates Rac GTPase and is often deleted during
tumor progression.
57 A recent study in rats indicates
that DOCK4 is predominantly expressed in the
hippocampus as well as in the lung.
58 This study
further demonstrated that in cultured hippocampal
neurons, DOCK4 is upregulated at the same time as
dendrites start growing, and that knockdown of this
gene by RNA interference results in impaired den-
dritic morphogenesis.
The association result for rs2217262 indicates that
the common allele in the population is associated
with increased risk for autism, or the minor allele is a
‘protective’ variant. It has been shown that in
presence of missing data, SNPs with a low MAF
may show a bias in TDT, resulting in artificial
overtransmission of the common allele.
59 This pro-
blem is not likely to apply to rs2217262, as this
association was supported also by case–control
analysis.
Although only the rs2217262 association was
confirmed by replication analysis, suggesting that
the other results may represent false positives, this
polymorphism (with MAF only about 5%) would not
alone account for the linkage signal seen at AUTS1 in
the IMGSAC sample. It is thus possible that multiple
loci might contribute to the overall linkage seen for
this region, and that the other significant SNPs from
primary analysis may in reality be true signals but
with lower OR, which our replication study was
underpowered to detect. We do recognize that several
limitations may have affected our replication sample.
The primary sample was composed of trios selected
from multiplex families based on IBD sharing, thereby
more likely to be enriched for susceptibility alleles.
By contrast, the replication population was a more
heterogeneous sample, not preselected on linkage,
and was mostly composed of singleton families.
Power calculation suggested that our replication
sample (IMGSAC-R and ND) should give us sufficient
power to replicate the most significant primary
results. However, the well-known ‘winners curse’
theory also suggests that the effect sizes from the
initial study may have been overestimated, thus
requiring a much larger sample for replication. We
did not detect presence of structure in the combined
IMGSAC primary and IMGSAC-R samples, but it is
possible that heterogenity may be present among the
different samples used in this study (ND, Mount Sinai
and University of Washington). This could have
also contributed to the lack of replication, as could
have gene–environment interactions, when different
environmental exposures are present between popu-
lation samples.
De novo and/or inherited CNVs are emerging as
important causes of ASDs and other complex dis-
orders.
8,11–13 Hence we exploited our dense SNP
genotyping data to mine for structural variants. The
most interesting discovery is the occurrence of
deletions and duplications in four independent
families in the IMMP2L/DOCK4 locus, given the
coincident SNP association also seen for these genes.
A maternal deletion was transmitted to both affected
sons and the unaffected daughter in family 15-0084.
In all other instances (two deletions and one
duplication) the second affected sib did not inherit
the CNV. Interestingly, the maternally segregating
deletion extends to the 30 end of the DOCK4 gene,
whereas the non-segregating deletions or those iden-
tified in controls and in the DGV were limited to
IMMP2L. Taken together, these data seem to suggest
that a copy number loss of DOCK4 may influence
susceptibility to ASDs, whereas duplications may not
be damaging. The effect of DOCK4 deletions might be
less penetrant in women because the mother and the
unaffected daughter also carried the deletion. Larger
studies will be needed to confirm this hypothesis.
The predominantly gene-based nature of our study
represents a possible limitation, as we may have
missed susceptibility alleles in intergenic regions.
Recent findings from the ENCODE Consortium em-
phasize the importance of looking at noncoding
sequence, as several functional elements in the
genome seem to be in these regions.
60 We attempted
to minimize this limitation by including several SNPs
in non-genic evolutionary conserved elements.
Our study also suggests that no common variants of
large effect size are present within genic regions at
AUTS1 and AUTS5 and highlights the importance of
very large sample sizes for identification of robust
associations and rare CNVs with sufficient power for
statistical significance. Evidence from recent genome-
wide association studies for various disorders clearly
shows that effect sizes for loci contributing to
complex traits are generally lower than those pre-
dicted a few years ago.
61 Several whole-genome
association and CNV studies for autism are currently
in progress by large consortia, and it will be interest-
ing to see if any of the genes highlighted by this study
are also identified by these extensive studies.
It is possible that rare variants, both point muta-
tions and CNVs, may account for a larger fraction of
the overall genetic risk in complex psychiatric
disorders than previously assumed. The present
study was not designed to assess the contribution of
rare sequence variants and our results do not preclude
that the chromosome 2q and 7q linkage regions may
harbor rare variation showing allelic heterogeneity
across families, which may require resequencing to
uncover.
The inconclusive findings identified with this
study reflect the status of the field of autism genetics
and suggest that classical approaches such as linkage
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Molecular Psychiatryand association analyses alone may not be sufficient
to deal with the genetic and phenotypic heterogeneity
seen in autism. One recent study of note used
homozygosity mapping to uncover a number of large
homozygous deletions in consanguineous pedigrees,
highlighting the utility of this approach for hetero-
geneous disorders like autism.
10 Another successful
study found linkage to 15q13.3–q14 in a subset of
families with IQ X70, suggesting that the use of
informative subphenotypes to define homogeneous
sets of ASD families could be very important in
detecting susceptibility loci involved in autism.
62
Finally, another report indicated that level of somatic
CNVs between MZ twins may be higher than
expected.
63 If confirmed, this finding could be a
powerful tool for identification of autism suscept-
ibility loci in MZ twins with a discordant phenotype.
We believe a combination of these (and other) novel
approaches, together with traditional methods will be
required to uncover all the genes and biological
pathways leading to autism.
In summary, the present high-density SNP associa-
tion and CNV screen have provided evidence
that variants in the IMMP2L/DOCK4 locus on chro-
mosome 7 and in ZNF533 on chromosome 2 may
increase susceptibility to ASDs. Association of the
common allele of SNP rs2217262 in DOCK4 was
supported by an independent replication, whereas
the associations in IMMP2L and ZNF533 are not
sufficiently significant in the context of multiple
testing and warrant further studies.
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